Pregnant people with schizophrenia have threefold risk of interpersonal violence Isra Zaman7 March 2023 9:15 AM ISTPregnant and postpartum people with schizophrenia have a more than threefold increase in the risk of an emergency department visit for interpersonal...
Antipsychotics vary in weight gain and metabolic side effects in Schizophrenic patients through treatment courses Dr.Niharika Harsha B20 Feb 2023 8:00 PM ISTA new study found that the type of metabolic side effects varied among various antipsychotics in mid to long-term treatment. They differed in weight...
People from poorest backgrounds far more likely to develop mental disorder later in life Dr. Kamal Kant Kohli8 Feb 2023 7:45 PM ISTResearchers have found in a new study that least wealthy people are more likely to have mental health disorder later in life. Compared to people from...
FDA okays long acting risperidone for Schizophrenia and Bipolar 1 Disorder Dr. Kamal Kant Kohli21 Jan 2023 9:45 AM ISTThe Food and drug administration has approved biweekly risperidone for the treatment of schizophrenia and bipolar I disorder.Rykindo was developed by...
Zydus Lifesciences arm bags USFDA approval for schizophrenia drug Brexpiprazole Ruchika Sharma14 Jan 2023 11:13 AM ISTThe drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India.
Experimental antipsychotic evenamide found effective as add-on therapy in treatment-resistant schizophrenia Dr. Kamal Kant Kohli9 Jan 2023 9:45 AM ISTAccording to a new research experimental antipsychotic evenamide reduces severity of symptoms when added to an existing antipsychotic in treatment-...
Once-daily Emraclidine novel and safe treatment of Schizophrenia: LANCET Dr.Niharika Harsha B3 Jan 2023 9:30 AM ISTU.S.A: Researchers from the U.S.A found that Emraclidine is a safe drug as a once-daily treatment for schizophrenia and does not need any drug...
Escitalopram and Citalopram effective on Depressive Symptoms in Schizophrenia patients? Dr. Nandita Mohan3 Jan 2023 9:00 AM ISTSchizophrenia is a serious neurodevelopmental psychiatric disorder characterized by impaired thought process and cognition, poor emotional...
Iloperidone Shown to be Effective in Bipolar I Disorder in Phase III Clinical Study Dr. Kamal Kant Kohli23 Dec 2022 10:30 AM ISTAccording to results from a phase 3 study, Iloperidone was linked to significant improvement in adults with bipolar I disorder.In clinical study...
Schizophrenia strongly linked to risk of dementia compared to depression or anxiety Isra19 Dec 2022 8:00 PM ISTNon-affective psychotic disorders have been associated with an increased risk of developing dementia. However, research in this area remains limited,...
FDA Approves cariprazine as Adjunctive Treatment for Major Depressive Disorder Dr. Kamal Kant Kohli19 Dec 2022 10:00 AM ISTThe US Food and Drug Administration (FDA) has approved cariprazine (VRAYLAR) as an adjunctive therapy to antidepressants for the treatment of major...
Medical Bulletin 5/December/2022 Dr. Nandita Mohan5 Dec 2022 2:30 PM ISTHere are the top medical news for the day:Trouble sleeping? You could be at risk of type 2 diabetesAs the Christmas season starts to ramp up,...
